07 Sept 2026
Forschungszulage for Germany's automotive industry
In the German economy, the automotive industry is one of the highly contributing sectors to its growth over the decades. The automotive sector adds value to the country's economy by having more than 800,000 people employed in various vehicle manufacturing companies, revenue generated over several hundred billion euros, and having a leading international trade position. And the automotive industry alone accounts for around 30% of the expenditure incurred within the German enterprise sector.
Innovations and R&D in the automotive sector have experienced a closely interwoven connection between technical universities and research institutions like the Fraunhofer Institutes focusing on developing new technologies in the field. The research and innovation here is not limited to the globally famous car brands, but the ecosystem also includes the OEMs (Original Equipment Manufacturers), which include Tier 1 suppliers of complex vehicle components, Tier 2 manufacturers of standard parts, and Tier 3 suppliers of raw materials.
Germany's automotive brilliance is specifically defined by the objective of making premium automobile products. Technological innovations are a core activity in this sector prior to any new market launch.
Challenges the automotive industry faces in innovation and R&D
Even with disruptive automobile production and innovation, the automotive sector faces transformational challenges. The focus on sustainable and emission-free mobility is changing the mode of international competition in terms of R&D and also with manufacturing components and supply chain. An upper hand on traditional advantages like mere engineering excellence and manufacturing capacity is no longer sufficient to maintain international leadership.
Some of the key challenges redefining the industry include escalating cost pressures, strict environmental regulations, high technology demands, and geopolitical and supply chain uncertainty.
Challenges in accessing Forschungszulage
The Research Allowance Act introduced in 2020, offers a tax based incentive to the companies commencing R&D aimed at strengthening innovation and research. Even though encompassing wider eligibility criteria and a less bureaucratic process in the application stages, there are a few barriers the automotive research projects face in successfully claiming research allowance.
Common hurdles include:
1. Complexity in Application
Gaining in-depth understanding of Forschungszulage, its eligibility criteria and documentation of R&D activities in compliance with standard regulations is an extensive and complex step for the teams focusing on core research work.
2. Lack of Awareness
There is a chance that the companies with good research projects, especially the smaller companies, are unaware of the research allowance and that they qualify to claim it. This may result in unclear documentation of research work and costs which are important and need accuracy if they decide to seek research allowance in the future.
3. Communication gap between technical team and funding application requirements
In most of the cases of research projects, the technical team focuses only on pure research activities and funding support for the project is generally not part of their responsibilities. But to prepare a successful application for Forschungszulage, the technical team's involvement is crucial as it requires clear definitions of the technical complexities of the research work. Here, when the internal teams lack coordination, it may lead to an ambiguous application draft while claiming research allowance.
Examples of R&D activities that qualify for Forschungszulage claim
A few examples of the research work that are eligible and not eligible to claim research allowance include,
Focus area | Eligible R&D scope | Standard engineering (Ineligible) |
E-Mobility | Developing novel thermal management architectures or power electronics integrations. | Routine scaling or assembly optimization of existing battery packs. |
Autonomous driving | Engineering predictive sensor-fusion algorithms or novel LiDAR calibration under extreme conditions. | Implementing or calibrating off-the-shelf ADAS software components. |
Sustainable design | Material science research to achieve structural lightweighting with untried composite materials. | Geometric redesigns using standard automotive steel for aesthetics. |
Connected systems | Developing proprietary, low-latency V2X communication protocols or over-the-air (OTA) security architectures. | Routine UI/UX design or integration of standard infotainment features. |
Conclusion
Germany's automotive industry is experiencing a transformation like never before. With shifting market conditions and an intensified focus on sustainable, emission-free mobility, the way ahead demands cutting-edge innovation, strategic investments, and robust government backing.
The Forschungszulage is a vital mechanism in this transition, serving as a strategic tool designed specifically to maintain and enhance Germany's engineering excellence. Rather than treating it as a routine year-end tax task, automotive companies must view this allowance as a core asset to de-risk and scale their R&D initiatives.
Connect with innoscripta today to seamlessly align your engineering workflows with the strict application requirements, ensuring your R&D projects receive the full financial backing they deserve.
You Might Also Like
24 Sept 2026
R&D tax incentives for multinational companies: Building a global strategy
A multinational company focusing on research and development often organises it through global business units instead of each in individual countries. Several engineering, software, electronics and product development teams collaborate on one initiative across borders, making innovation an internal rather than a regional activity. Despite this, R&D tax incentives are still predominantly pursued on a country-by-country basis. Companies appoint and retain separate advisors for individual jurisdictions, such as Germany, France, or the UK. This fragmented approach results in duplicated efforts, inconsistent documentation, limited visibility, and overlooked incentive opportunities in unassessed regions. Multinational groups should align their strategy for R&D incentives with their approach to innovation with a global perspective. Instead of evaluating individual tax regimes, companies need to analyse their international R&D initiatives, identify where research activities occur, and determine which national incentive programmes are accessible and applicable across the broader organisation. Key advantages of a global approachUnified strategy: Replaces disconnected, country-specific approach with a centralised global funding plan.Streamlined operations: Reduces shortfalls in internal coordination and eliminates redundant interviews with multiple regional advisors.Standardised governance: Enables consistent documentation and compliance standards across multiple jurisdictions.Increased transparency: Generates clear visibility into global R&D expenditure and tax incentive claims. Risk mitigation: Improves overall compliance and lowers audit vulnerability. Maximised value: Increases likelihood of identifying previously overlooked or untapped funding opportunities.Centralised tracking and execution: Streamlines claim management, application status, and refunds using a single software system across jurisdictions.To support this centralised model, this article also evaluates key R&D incentive programmes across Europe and USA, comparing their structures and key features. The goal is not to designate a single best jurisdiction, but to assist CFOs, tax leaders, and innovation teams in developing a holistic international strategy that maximises values across the entire corporate group. Why international companies should stop thinking in countriesEven in the present, most advisory firms continue to approach R&D tax incentives strictly by jurisdictions. For example, a specialist in France handles French claims, an advisor in Germany manages German R&D tax credit, and another set of advisors oversee other countries. While each may organise local filing, few evaluate how the overall corporate group enhances its global R&D funding strategy.The fundamental concern points toward a single angle: multinational companies operate through global business units and collaborate on R&D projects across borders, and do not operate in isolated country silos. A clear example is a company that structures its engineering, software, electronics, and product teams around international projects. A single initiative might involve software developers in Germany, engineers in Sweden, data scientists in Portugal, and testing teams in the United States.And the company will certainly experience advisory firms analysing their respective countries, the questions and information they assess might be repetitive, but each advisor only sees one country. The result of this localised approach? Duplicated work or lack of single stop solution. A holistic global perspectiveInternational groups should assess their global R&D footprint before evaluating individual national tax credits.Instead of asking:“Which tax credit is available in Germany?”The primary question should be:“Where do our global R&D activities take place, and which incentive programmes apply across our entire innovation portfolio?”Building a coordinated international funding plan requires end-to-end understanding of the corporate group's organisational structure, business units, development workflows, and global allocation of R&D expenditure prior to selecting specific incentive regimes.Evaluating regional opportunitiesHaving established why multinational companies should take a global approach, the next step is to evaluate the specific opportunities available across jurisdictions, the following example includes Germany, France, the UK, the Netherlands, Denmark, Sweden, Austria, Romania, and the USA.While all R&D incentives aim to strengthen innovation, programmes differ significantly in their funding mechanisms, reimbursement models, documentation standards, and financial impact. Options range from refundable tax credits and reduced payroll taxes to enhanced tax deductions. Understanding these structural differences is essential to building an efficient, high-value international R&D funding strategy.The comparison below summarises how certain jurisdictions structure their R&D tax credits, funding limits, and operational mechanisms:CountryInstrumentBenefit / RateCap / LimitRefundable / Cash effectKey featureGermanyForschungszulage 25% standard; up to 35% for SMEsUp to €3 Million credit from 2026; up to €4.2 Million for SMEs depending on rulesRefundable if credit exceeds tax liabilityStrong cash-flow tool; evaluated across total group entity spendFranceCIR30% up to €100 Million eligible R&D spend; 5% aboveNo absolute capTax credit / potential reimbursementOne of Europe’s most generous schemes, but documentation requirements are highUKMerged R&D Scheme / ERIS20% gross credit; approx. 15% net; up to approx. 27% for R&D-intensive loss-making SMEsNo general annual funding cap; payable SME cap may applyCash payment or tax reductionNew merged scheme since April 2024; Additional Information Form mandatoryNetherlandsWBSO36% on first €391k R&D wage costs; 16% above; 50% for start-upsNo annual assessment limitPayroll tax / social security reductionMust be applied for before R&D activities startDenmarkR&D Tax Credit22% refundable credit for loss-making R&D expenditureMax. DKK 5.5 Million refund; cap expected to increase from 2027Refundable, but only in tax-loss positionParticularly attractive for loss-making R&D companiesSwedenForskningsavdrag / R&D payroll reliefReduction of employer social security contributions for qualifying R&D employeesBased on payroll/employer contribution rules; not a classic project-cost tax creditPayroll cost reductionNot a classic R&D tax credit; most relevant for companies with Swedish R&D staffAustriaForschungsprämie14% of eligible R&D expenditureNo overall funding cap; contract research capped at €1 Million per annumCash premium / tax-free bonusCan be claimed retroactively for up to 4 yearsRomaniaR&D Tax Credit10% of eligible R&D expenditureUnused balance can be offset or refundedRefundable / recoverable surplusNew statutory credit from 2026; alternative to the former 50% super-deductionUSAR&D Tax Credit, IRC §41Federal and state credits based on QREsDepends on federal and state rulesTax credit; Strong audit focus on contemporaneous documentation and substantiationAcross major innovation economies, R&D incentives have evolved into an important financial tool, and European markets offer particularly diverse models: Germany provides Forschungszulage in the form of R&D tax credits, or as a cash refund if the taxable amount is less than the research allowance, while France’s CIR offers 30% on the first €100 million of eligible R&D expenditure and has no overall funding cap. The USA’s R&D- Tax-Credit scheme provides a standardised credit mechanism, whereas Austria offers a straightforward 14% tax-free research premium. The Netherlands and Sweden take a more payroll-oriented approach, reducing the ongoing employment costs associated with qualifying R&D teams. Denmark, meanwhile, specifically supports loss-making innovators through a 22% refundable credit, making it particularly relevant during investment-heavy phases before profitability.However, the attractiveness of these programmes spans beyond the headline funding rates. Refundability, eligible cost categories, application timing, funding caps, and documentation requirements also determine how companies approach these opportunities and, ultimately, the financial value they can realise. For example, in the United States, federal and state R&D credits can create substantial benefits, but rigorous substantiation and traceability between activities, employees, and costs are crucial for a claim to be successful. For multinational companies, the key is therefore not merely identifying the country with the highest potential R&D incentive or hiring individual advisors for each country, but developing a coordinated R&D funding strategy that enhances financial value, eligibility, and compliance requirements across jurisdictions through a centralised approach.We also recommend reading the article “How international R&D incentives impact financial statements: A guide for CFOs”.Take a global view of your R&D fundingIf your company conducts R&D across multiple countries yet manages each government-backed R&D incentive through separate local advisors and processes, there may be significant potential to achieve greater coordination, transparency, and financial value through a centralised approach.innoscripta supports multinational companies in assessing their global R&D footprint, identifying qualifying R&D initiatives and applicable funding opportunities across jurisdictions, and managing R&D incentives through a holistic approach. This is supported by Clusterix, our intuitive R&D project management software, which facilitates compliance, documentation, and claim management.Talk to our team to explore how your existing international R&D initiatives can be integrated into a coordinated global funding strategy.
28 Sept 2026
DER AKTIONÄR on innoscripta’s growth, international scaling and AI strategy
DER AKTIONÄR interviews CFO Alexander Meyer and COO Sebastian Schwertlein about innoscripta’s operational development, international growth and continued expansion of its software systems. The interview covers the 43% increase in revenue and 49% rise in EBIT in the first half of 2026, expansion into the United Kingdom, France and the US, and the role of AI in making internal workflows more efficient.Read more: https://www.deraktionaer.de/artikel/aktien/geheime-ki-gewinner-kennen-sie-diese-deutsche-aktie-20409622.html
